Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 15, 2015 (11 years ago)

Methylcobalamin 5000 mcg/mL Injectable

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Methylcobalamin 5000 mcg/mL Injectable, 2 mL vial, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ 07928.

Drug: Methylcobalamin

Recalling firm
Liberty Drug & Surgical
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1382-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Methylcobalamin recalls

See all

Other recalls by Liberty Drug & Surgical

All 2015 recalls
Class II · Moderate risk

Methylcobalamin 1

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1404-2015
Class II · Moderate risk

Hydroxocobalamin

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1402-2015
Class II · Moderate risk

Doxycycline/0.9% NaCl 300 mg/500 mL IV

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1401-2015